Axis NIFTY Healthcare ETF-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.
₹164.94-0.32%
24 Jul 2026
Similar ETFs
Side-by-side comparison of Axis NIFTY Healthcare ETF-Growth with similar ETFs — tracking error, returns, AUM and expense ratio.
| Period | This Fund | Category Avg | Category Rank |
|---|---|---|---|
| 1Y Return | +10.43% | 10.34% | 15 / 29 |
| 3Y Return | +20.95% | 21.02% | 10 / 18 |
| 5Y Return | +12.96% | 13.29% | 8 / 13 |
| 10Y Return | — | 13.50% | — |
Trailing annualised returns (%). Category rank: lower is better. Green = top third of category.
ETFs in Equity: Sectoral-Pharma
Top ETFs by AUM in the Equity: Sectoral-Pharma category — see how Axis NIFTY Healthcare ETF-Growth compares on size and returns.
ETFs Tracking NIFTY Healthcare Total Return Index.
Top ETFs tracking the NIFTY Healthcare Total Return Index. — sorted by AUM to show the largest options available.
Frequently Asked Questions
Which ETFs are similar to Axis NIFTY Healthcare ETF-Growth?
ETFs similar to Axis NIFTY Healthcare ETF-Growth in the Equity: Sectoral-Pharma category include Nippon India Nifty Pharma ETF-Growth, ICICI Prudential Nifty Healthcare ETF-Growth, and Aditya Birla Sun Life Nifty Healthcare ETF-Growth. These ETFs follow a comparable investment mandate and are benchmarked against similar indices. You can compare them in detail — across returns, risk metrics, expense ratio, and portfolio composition — using the ETF comparison tool on sharpely.
What is the rank of Axis NIFTY Healthcare ETF-Growth in its category?
On a 3-year return basis Axis NIFTY Healthcare ETF-Growth is ranked 10 out of 18 ETFs in the Equity: Sectoral-Pharma category as of 23 Jul 2026. On a 5-year return basis it ranks 8 out of 13. Consistently ranking in the top across multiple time periods is a stronger signal of ETF quality than a single-period rank.
How does Axis NIFTY Healthcare ETF-Growth's expense ratio compare to similar ETFs?
Axis NIFTY Healthcare ETF-Growth has an expense ratio of 0.44%. The peers Nippon India Nifty Pharma ETF-Growth has an expense ratio of 0.21% and ICICI Prudential Nifty Healthcare ETF-Growth has 0.15%. Over the long term, a higher expense ratio can meaningfully drag on returns, so it is worth evaluating whether the ETF's performance justifies the additional cost.
How does Axis NIFTY Healthcare ETF-Growth's AUM compare to similar ETFs?
Axis NIFTY Healthcare ETF-Growth has an AUM of ₹23.87 crore. The peers Nippon India Nifty Pharma ETF-Growth has an AUM of ₹1,622.31 crore and ICICI Prudential Nifty Healthcare ETF-Growth has ₹221.18 crore. A large AUM can sometimes limit a ETF's ability to take meaningful positions in mid and small-cap stocks, as larger trades can move prices. This is particularly relevant for ETFs that invest outside large caps.
Which ETF has the best 3-year returns in the Equity: Sectoral-Pharma?
The top performing ETF in the Equity: Sectoral-Pharma category on a 3-year basis is Motilal Oswal BSE Healthcare ETF-Growth with a CAGR of 23.00% as of 23 Jul 2026. Axis NIFTY Healthcare ETF-Growth has delivered 20.95% CAGR over the same period, ranking 10 out of 18 ETFs. You can view and compare the full category ranking on sharpely.
How does Axis NIFTY Healthcare ETF-Growth rank in risk-adjusted returns vs peers?
On a risk-adjusted basis, Axis NIFTY Healthcare ETF-Growth has a Sharpe ratio of 0.94 compared to the Equity: Sectoral-Pharma average of 0.98 as of 23 Jul 2026. It ranks 5 out of 5 ETFs in its category on Sharpe ratio.